Skip to main content

Advertisement

SpringerLink
Log in

Multiple sclerosis and oncocytic thyroid carcinoma: fortuitous or drug-related association?

  • Letter to the Editor
  • Published:
Neurological Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Decallonne B, Bartholomé E, Delvaux V, D'haeseleer M, El Sankari S, Seeldrayers P, Van Wijmeersch B, Daumerie C (2018) Thyroid disorders in alemtuzumab-treated multiple sclerosis patients: a Belgian consensus on diagnosis and management. Acta Neurol Belg 118(2):153–159

    Article  Google Scholar 

  2. Witte ME, Bø L, Rodenburg RJ, Belien JA, Musters R, Hazes T, Wintjes LT, Smeitink JA, Geurts JJ, De Vries HE, van der Valk P, van Horssen J (2009) Enhanced number and activity of mitochondria in multiple sclerosis lesions. J Pathol 219:193–204

    Article  Google Scholar 

  3. Du J, Wang Y, Hunter R, Wei Y, Blumenthal R, Falke C, Khairova R, Zhou R, Yuan P, Machado-Vieira R, McEwen BS, Manji HK (2009) Dynamic regulation of mitochondrial function by glucocorticoids. Proc Natl Acad Sci U S A 106:3543–3548

    Article  Google Scholar 

  4. Goudy K, Aydin D, Barzaghi F, Gambineri E, Vignoli M, Ciullini Mannurita S, Doglioni C, Ponzoni M, Cicalese MP, Assanelli A, Tommasini A, Brigida I, Dellepiane RM, Martino S, Olek S, Aiuti A, Ciceri F, Roncarolo MG, Bacchetta R (2013) Human IL2RA null mutation mediates immunodeficiency with lymphoproliferation and autoimmunity. Clin Immun 146:248–261

    Article  Google Scholar 

  5. Hale G, Xia MQ, Tighe HP, Dyer MJ, Waldmann H (1990) The CAMPATH-1 antigen (CDw52). Tissue Antigens 35:118–127

    Article  Google Scholar 

Download references

Acknowledgements

The authors thank Dr. E Maillart as well as Dr. E Sabattini, Dr. B Bisig, Dr. R Scott, Dr. J Smith, Dr. S Singh, Dr. V Vasiliu, and Pr P Gaulard, as well as J Raleche, M Rodrigues, S El Sayeh, V Guzal, C Van Vetteren, I Pluchart, L Jovanov, F Spindler, B Mechekour, N Delva, F Bouchard, F Aurejac, B Mechekour, M De Souza, MC Portenier, and the BIUM and NCA/Avicenne/APHP teams.

Author information

Authors and Affiliations

  1. Service d’Anatomie pathologique, APHP GHU Avicenne, Universite Paris Nord Sorbonne Cite, 125 rue Stalingrad, 93009, Bobigny, France

    Adriana Handra-Luca

  2. Université Paris Nord Sorbonne Cité, UFR SMBH, Bobigny, France

    Adriana Handra-Luca

  3. Unit of Hematopathology, S. Orsola Malpighi Hospital, Bologna, Italy

    Francesco Bacci

Authors
  1. Adriana Handra-Luca
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Francesco Bacci
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Adriana Handra-Luca.

Ethics declarations

Ethical statement

The statements noted on the Internet page of the journal (Instructions for Authors) are fullfilled. Enclosed is the pdf of the Internet page.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Handra-Luca, A., Bacci, F. Multiple sclerosis and oncocytic thyroid carcinoma: fortuitous or drug-related association?. Neurol Sci 40, 883–885 (2019). https://doi.org/10.1007/s10072-018-3640-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-018-3640-7

Search

Navigation